Download PDF
1 / Pages

Other users also viewed these articles

Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region Saleh A. Alqahtani; Yusuf Yilmaz; Mohamed El-Kassas; Khalid Alswat; Mohamed Mawardi; Faisal M. Sanai; Faisal Abaakhail; Saad Alghamdi; Waleed K. Al-Hamoudi; Fatema Nader; Maria Stepanova; Zobair M. Younossi;
10.1016/j.aohep.2024.101569
Safety and efficacy of dyslipidemia treatment in NAFLD patients: a meta-analysis of randomized controlled trials Mohamed Abdallah; Landon Brown; John Provenza; Raseen Tariq; Smitha Gowda; Ashwani K. Singal;
Ann Hepatol. 2022;27:
Clinical treatment of cholangiocarcinoma: an updated comprehensive review Alessandra Elvevi; Alice Laffusa; Miki Scaravaglio; Roberta Elisa Rossi; Raffaella Longarini; Anna Maria Stagno; Laura Cristoferi; Antonio Ciaccio; Diego Luigi Cortinovis; Pietro Invernizzi; Sara Massironi;
Ann Hepatol. 2022;27: